This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Biotechnology, Ibisworld

NEW YORK, Nov. 20, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Biotechnology, Ibisworld

http://www.reportlinker.com/p01045182/Global-Biotechnology-Ibisworld.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biotechnology

Global Biotechnology

In the past five years, the global recession tempered demand for nonessential health products and reduced funding for biotechnology research and development from private investors. Despite these factors, industry firms thrived on the back of technological advances that facilitated new discoveries and stimulated greater demand from firms in the pharmaceuticals and agricultural sectors. Industry growth is forecast to continue skyrocketing in the next five-year period as investment in biotechnology from around the world increases, particularly from emerging economies.

Firms in this industry primarily engage in the application of living organisms or molecular and cellular techniques to develop products that are used in agriculture, food, industrial and medicine production.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

TABLE OF CONTENTS

ABOUT THIS INDUSTRY

Industry Definition

Main Activities

Similar Industries

Additional Resources

INDUSTRY PERFORMANCEExecutive SummaryKey External DriversCurrent PerformanceIndustry OutlookIndustry Life Cycle

PRODUCTS & MARKETS

Supply Chain

Products & Services

Demand Determinants

Major Markets

International Trade

Business Locations

COMPETITIVE LANDSCAPEMarket Share ConcentrationKey Success FactorsCost Structure BenchmarksBasis of CompetitionBarriers to EntryIndustry Globalization

MAJOR COMPANIES

OPERATING CONDITIONSCapital IntensityTechnology & SystemsRevenue VolatilityRegulation & PolicyIndustry Assistance

KEY STATISTICS

Industry Data

Annual Change

Key Ratios

JARGON

MAJOR COMPANIES

Amgen Inc.

Merck KGaA

Roche Holding AG To order this report: Biotechnology Industry: Global Biotechnology, Ibisworld Nicolas BombourgReportlinkerEmail: nicolasbombourg@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs